Semra Paydaş
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Viral-associated cancers and disorders
- Lung Cancer Research Studies
Papers in
- Oncology 98
- Viral-associated cancers and disorders 20
- Vascular Tumors and Angiosarcomas 11
- Hematology 51
- Acute Myeloid Leukemia Research 23
- Multiple Myeloma Research and Treatments 12
- Co-authors
- Suzan Zorludemir (22 shared papers)Melek Ergin (40 shared papers)Berksoy Şahin (32 shared papers)Sinan Yavuz (35 shared papers)Gülşah Şeydaoğlu (26 shared papers)Umut Dişel (29 shared papers)Emine Kılıç Bagir (21 shared papers)Gülfiliz Gönlüşen (14 shared papers)
- Journals
- Leukemia Research (23 papers)Medical Oncology (7 papers)Annals of Oncology (6 papers)Critical Reviews in Oncology/Hematology (6 papers)American Journal of Hematology (6 papers)
- Partner nations
- TürkiyeUnited StatesIndia
In The Last Decade
Semra Paydaş
249 papers receiving 3.8k citations
Semra Paydaş's Hit Papers
Peers
Comparison fields: 5 of 117
- Hematology 670
- Oncology 1.5k
- Genetics 492
- Pathology and Forensic Medicine 650
- Pulmonary and Respiratory Medicine 672
Countries citing papers authored by Semra Paydaş
This map shows the geographic impact of Semra Paydaş's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Semra Paydaş with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Semra Paydaş more than expected).
Fields of papers citing papers by Semra Paydaş
This network shows the impact of papers produced by Semra Paydaş. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Semra Paydaş. The network helps show where Semra Paydaş may publish in the future.
Co-authors
The 25 scholars most cited alongside Semra Paydaş, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 277 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial Hit paper breakdown → | 2021 | 602 |
| 2 | 2006 | 213 | |
| 3 | 2019 | 137 | |
| 4 | 2002 | 109 | |
| 5 | 2016 | 84 | |
| 6 | 2000 | 81 | |
| 7 | 2011 | 78 | |
| 8 | 2015 | 74 | |
| 9 | 2009 | 73 | |
| 10 | 2003 | 63 | |
| 11 | 2016 | 59 | |
| 12 | 2005 | 58 | |
| 13 | 1996 | 58 | |
| 14 | 2000 | 55 | |
| 15 | 2012 | 47 | |
| 16 | 1997 | 43 | |
| 17 | 2003 | 43 | |
| 18 | 1999 | 43 | |
| 19 | 2015 | 41 | |
| 20 | 2009 | 41 |
About Semra Paydaş
Semra Paydaş is a scholar working on Oncology, Hematology, Pathology and Forensic Medicine, Genetics and Pulmonary and Respiratory Medicine, having authored 277 papers that have together received 3.9k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (49 papers), Chronic Lymphocytic Leukemia Research (31 papers), Acute Myeloid Leukemia Research (23 papers), Viral-associated cancers and disorders (20 papers), CNS Lymphoma Diagnosis and Treatment (15 papers), Lung Cancer Treatments and Mutations (12 papers), Multiple Myeloma Research and Treatments (12 papers) and Vascular Tumors and Angiosarcomas (11 papers). The work is most often cited by research in Hematology (670 citations), Oncology (1.5k citations), Genetics (492 citations), Pathology and Forensic Medicine (650 citations) and Pulmonary and Respiratory Medicine (672 citations). Semra Paydaş has collaborated with scholars based in Türkiye, United States and India. Frequent co-authors include Suzan Zorludemir, Melek Ergin, Berksoy Şahin, Sinan Yavuz, Gülşah Şeydaoğlu, Umut Dişel, Emine Kılıç Bagir, Gülfiliz Gönlüşen, Kahraman Tanrıverdi and Fikri Başlamıslı. Their work appears in journals such as Leukemia Research, Medical Oncology, Annals of Oncology, Critical Reviews in Oncology/Hematology and American Journal of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.